MCUJF (MCUJF) Stock Price & Analysis
MCUJF (MCUJF) fell 6.25% to USD 0.75 as of June 10, 2026 at 08:00 UTC, according to Nexqual real-time market data.
MCUJF last closed at USD 0.8; the session ranged USD 0.75–0.75 on volume of 2,000 shares. Market capitalization is $8.40M, with a 52-week range of USD 0.71–0.97 (PNK). Source: Nexqual, June 10, 2026 at 08:00 UTC.
Key Statistics (as of June 10, 2026 at 08:00 UTC)
| Price | USD 0.75 |
|---|---|
| Change | ▼ 6.25% (down) |
| Previous Close | USD 0.8 |
| Open | USD 0.75 |
| Day Range | USD 0.75 – 0.75 |
| 52-Week Range | USD 0.71 – 0.97 |
| Volume | 2,000 shares |
| Market Cap | $8.40M |
| Exchange | PNK |
Technical Analysis (MCUJF)
Nexqual's technical model rates MCUJF "SELL" based on 2 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 08:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.5 (neutral) |
| vs SMA50 | Below (USD 0.82) |
| MACD | -0 (negative) |
Analyst Ratings (MCUJF)
Wall Street analysts rate MCUJF "None", per Nexqual as of June 10, 2026 at 08:00 UTC.
| Consensus Rating | None |
|---|
Earnings (MCUJF)
| Next Earnings Date | 2026-08-19 |
|---|
Source: Nexqual, June 10, 2026 at 08:00 UTC.
Financials & Fundamentals (MCUJF)
| Total Revenue | $31.32M |
|---|---|
| Revenue Growth (YoY) | +44.90% |
| Gross Margin | +39.68% |
| Operating Margin | -4.62% |
| Profit Margin | -21.74% |
| ROE | -41.57% |
| Debt / Equity | 6.34 |
| Current Ratio | 1.04 |
| Total Cash | $1.54M |
| Total Debt | $803,000 |
| Free Cash Flow | $-987,750 |
Source: Nexqual, June 10, 2026 at 08:00 UTC.
Financial Health Score (MCUJF)
Nexqual rates MCUJF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 08:00 UTC.
| Growth | Critical — Revenue -31% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $2M cash, no debt |
| Cash Flow | Weak — FCF negative: -$988K, burning cash |
| Efficiency | Critical — ROE -42%, ROA -15.5% |
Ownership (MCUJF)
| Insider Ownership | +26.60% |
|---|---|
| Institutional Ownership | +23.10% |
| Shares Outstanding | 10.44M |
| Float | 5.29M |
Source: Nexqual, June 10, 2026 at 08:00 UTC.
Leadership (MCUJF)
MCUJF is led by Albert David Friesen (age 78), Founder, CEO, President & Chairman of the Board, per Nexqual as of June 10, 2026 at 08:00 UTC.
| Founder, CEO, President & Chairman of the Board | Albert David Friesen (age 78) |
|---|---|
| Vice President of Scientific & Medical Affairs | Reuben Saba |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CVALF | Covalon Technologies Ltd. | USD 1.52 | ▲ 0% |
| PFHO | Pacific Health Care Organizatio | USD 0.91 | ▼ 18.02% |
| PBSV | Pharma-Bio Serv, Inc. | USD 0.53 | ▼ 0.94% |
| VEXTF | Vext Science Inc. | USD 0.19 | ▼ 5% |
| MBXBF | MICROBIX BIOSYSTEMS | USD 0.2 | ▲ 8.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:00 UTC. This page is informational and not investment advice.